New paper published on uncovering the differential effects of Rivaroxaban, a direct oral anticoagulant, on extracellular vesicles (EVs) in patients with Venous Thromboembolism (VTE)

A new paper, “Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism” has been published in Proteomics – Clinical Applications. 

The paper delves into the unique protein profiles of important circulating Extracellular Vesicles, shedding light on potential anti-inflammatory and cardiovascular-protective impacts beyond Rivaroxaban's well-established anticoagulant properties. Grateful for the collaborative efforts in advancing our understanding of VTE treatment. 

Congratulations to all those involved including Professor Fionnuala Ní Aínle, Professor Sean Murphy and Dr Barry Kevane from UCD School of Medicine.  A special mention to Dr Luisa Weiss, UCD School of Biomolecular and Biomedical Science for leading on this project.

Read the free full text online at (opens in a new window)PROTEOMICS – Clinical Applications - Wiley Online Library.